Here are five of the biggest struggles companies are likely to encounter under FDA's new nutrition label proposal.
Under FDA’s current rules, companies list “sugar,” which includes a combination of both added and naturally occurring sugar. But 16% of the average American’s daily calories come from added sugar alone. While some of the culprits of added sugars are expected-soda, energy drinks, desserts, candy, fruit drinks-consumers might not realize that other, healthier foods might also be packed with sugar (cereal, canned fruit, sweetened yogurt). FDA believes that requiring companies to specifically disclose and quantify added sugar-that is, sugar added during the production process-may help Americans cut down on their sugar intake across the board.
Elizabeth Braithwaite, MPH, RDN, research and content manager for ESHA Research (Salem, OR), gives an example of how sugar would now be listed under the proposed regulation. “Currently a fruit drink that contains 25 g of sugar, including 15 g of added sugar, only reports 25 g of total sugar on the nutrition label. With the new added-sugar rule, the drink would report 25 g of total sugar and 15 g of added sugar.”
Still, considering the amount of added sugar out there, this change is likely to jar both healthy food and non-healthy-food companies alike. “I think that making added sugar a mandatory label component will be the item most controversial for food manufacturers,” Braithwaite predicts. Many more food products will become “more vulnerable” once their added-sugar content is exposed, she says.
Photo © iStockphoto.com/Maksud_kr
DOJ asks Utah court to dismiss FTC lawsuit against Xlear Inc.
March 11th 2025On March 10, the DOJ and the defendant filed a stipulation to dismiss with prejudice the lawsuit in which each party agrees “to be responsible for its own costs and fees and agrees that no party shall be responsible to any other party for any fines, costs, fees, or penalties arising from this case.”
HHS announces efforts to eliminate independent conclusion of GRAS
Published: March 11th 2025 | Updated: March 11th 2025U.S. Department of Health and Human Services (HHS) Secretary, Robert F. Kennedy Jr., is directing the acting U.S. Food and Drug Administration’s (FDA) acting commissioner to explore rulemaking that would eliminate the independent conclusion of GRAS provision.